4//SEC Filing
PETERS WILLIAM J 4
Accession 0001415889-24-018417
CIK 0001297184other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:26 PM ET
Size
7.3 KB
Accession
0001415889-24-018417
Insider Transaction Report
Form 4
PETERS WILLIAM J
DirectorCFO, EVP & TREASURER
Transactions
- Sale
Common Stock
2024-06-27$41.29/sh−635$26,222→ 94,103 total - Sale
Common Stock
2024-06-27$40.85/sh−2,961$120,947→ 94,738 total
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.20 to $41.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
- [F3]Includes 431 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.22 to $41.36, inclusive.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001263136
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:26 PM ET
- Size
- 7.3 KB